Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Altium Capital Management

Latest statistics and disclosures from Altium Capital Management's latest quarterly 13F-HR filing:

Top 5 stock holdings are Cymabay Therapeutics, Immunovant, ImmunoGen, ATXS, XTNT, and represent 28.59% of Altium Capital Management's stock portfolio.
Added to shares of these 10 stocks: Immunovant (+$12M), ALIM (+$9.1M), GPCR (+$7.8M), BHVN (+$7.5M), AMLX (+$6.4M), Karuna Therapeutics Ord (+$5.7M), SGMT, ImmunoGen, Apellis Pharmaceuticals Inc put, CRNX.
Started 23 new stock positions in ALIM, MRSN, Karuna Therapeutics Ord, GPCR, Anavex Life Sciences Corp put, Silverback Therapeutics, Aclaris Therapeutics Inc put, SLNO, DMAC, BHVN. BTMWW, MRNS, Apellis Pharmaceuticals Inc put, ABOS, ITCI, CDTTW, Immunovant, SGMT, ORIC, Anavex Life Sciences Corp call, SDOT, LITM, ACRS.
Reduced shares in these 10 stocks: Chinook Therapeutics (-$12M), Reata Pharmaceuticals Inc Cl A, , Bridgebio Pharma Inc put, Praxis Precision Medicines I, HRMY, Pepperlime Health Acqustn Co Class A, WAVS, KOD, Gri Bio.
Sold out of its positions in Bridgebio Pharma Inc put, Chinook Therapeutics, Colombier Acquisition Corp, Colombier Acquisition Corp, 1847 Goedeker, POLWQ, Fibrogen, Fibrogen, IMVT, Intercept Pharmaceuticals In. KOD, ZEVYW, MRAI, Mersana Therapeutics Inc call, Murphy Canyon Acquisition, Opy Acquisition Corp I, Reata Pharmaceuticals Inc Cl A, WAVS, Pepperlime Health Acqustn Co Class A.
Altium Capital Management was a net buyer of stock by $65M.
Altium Capital Management has $192M in assets under management (AUM), dropping by 45.13%.
Central Index Key (CIK): 0001746382

Tip: Access up to 7 years of quarterly data

Positions held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Altium Capital Management

Altium Capital Management holds 72 positions in its portfolio as reported in the September 2023 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Cymabay Therapeutics	6.2	$12M	+19%	800k	14.91	View chart
Immunovant Put Put Option	6.0	$12M	NEW	300k	38.39	View chart
ImmunoGen	6.0	$12M	+49%	725k	15.87	View chart
Astria Therapeutics (ATXS)	5.2	$10M		1.3M	7.46	View chart
Xtant Med Hldgs Com New (XTNT)	5.1	$9.8M	+43%	8.9M	1.10	View chart
Amylyx Pharmaceuticals (AMLX)	5.1	$9.8M	+189%	535k	18.31	View chart
Adma Biologics (ADMA)	5.1	$9.7M	+14%	2.7M	3.58	View chart
Alimera Sciences Com New (ALIM)	4.7	$9.1M	NEW	2.9M	3.10	View chart
Structure Therapeutics Sponsored Ads (GPCR)	4.1	$7.8M	NEW	155k	50.42	View chart
Crinetics Pharmaceuticals In (CRNX)	4.1	$7.8M	+94%	262k	29.74	View chart
Xenon Pharmaceuticals (XENE)	4.1	$7.8M		228k	34.16	View chart
Biohaven (BHVN)	3.9	$7.5M	NEW	287k	26.01	View chart
Axsome Therapeutics (AXSM)	3.4	$6.4M	+130%	92k	69.89	View chart
Karuna Therapeutics Ord	3.0	$5.7M	NEW	34k	169.09	View chart
Moonlake Immunotherapeutics Class A Ord (MLTX)	2.6	$5.0M		88k	57.00	View chart
Vera Therapeutics Cl A (VERA)	2.4	$4.6M	+178%	334k	13.71	View chart
Sagimet Biosciences Com Ser A (SGMT)	2.2	$4.3M	NEW	483k	8.80	View chart
Olema Pharmaceuticals (OLMA)	2.2	$4.1M	+8%	335k	12.35	View chart
Harmony Biosciences Hldgs In (HRMY)	2.0	$3.8M	-21%	117k	32.77	View chart
Apellis Pharmaceuticals Put Put Option	2.0	$3.8M	NEW	100k	38.04	View chart
Sarepta Therapeutics (SRPT)	1.9	$3.6M	+4%	29k	121.22	View chart
Dyne Therapeutics (DYN)	1.5	$2.8M	+103%	315k	8.96	View chart
Aclaris Therapeutics (ACRS)	1.4	$2.8M	NEW	403k	6.85	View chart
Acumen Pharmaceuticals (ABOS)	1.4	$2.7M	NEW	650k	4.15	View chart
Replimune Group (REPL)	1.4	$2.7M	+19%	155k	17.11	View chart
Oric Pharmaceuticals (ORIC)	1.3	$2.5M	NEW	419k	6.05	View chart
Cogent Biosciences (COGT)	1.2	$2.3M		235k	9.75	View chart
Phathom Pharmaceuticals (PHAT)	1.2	$2.3M	+6%	220k	10.37	View chart
Jasper Therapeutics	1.0	$2.0M		2.9M	0.70	View chart
Intra Cellular Therapies (ITCI)	0.8	$1.5M	NEW	28k	52.09	View chart
Soleno Therapeutics (SLNO)	0.7	$1.4M	NEW	47k	29.51	View chart
Mersana Therapeutics (MRSN)	0.7	$1.3M	NEW	1.1M	1.27	View chart
Diamedica Therapeutics Com New (DMAC)	0.7	$1.3M	NEW	496k	2.58	View chart
Aclaris Therapeutics Put Put Option	0.6	$1.2M	NEW	175k	6.85	View chart
Praxis Precision Medicines I	0.6	$1.1M	-54%	650k	1.71	View chart
Anavex Life Sciences Corp Call Call Option	0.5	$1.0M	NEW	155k	6.55	View chart
Anavex Life Sciences Corp Put Put Option	0.5	$1.0M	NEW	155k	6.55	View chart
Marinus Pharmaceuticals Com New (MRNS)	0.5	$1.0M	NEW	125k	8.05	View chart
Karyopharm Therapeutics (KPTI)	0.5	$992k		740k	1.34	View chart
Fat Brands *w Exp 07/16/202 (FATBW)	0.5	$974k	-11%	200k	4.87	View chart
Gri Bio	0.4	$808k	-55%	522k	1.55	View chart
Muscle Maker (SDOT)	0.3	$605k	NEW	865k	0.70	View chart
Doubledown Interactive Co Lt Ads (DDI)	0.3	$516k		61k	8.48	View chart
Ars Pharmaceuticals Put Put Option	0.2	$378k	NEW	100k	3.78	View chart
Snow Lake Res (LITM)	0.2	$290k	NEW	219k	1.32	View chart
Wearable Devices *w Exp 09/14/202 (WLDSW)	0.1	$168k		1.4M	0.12	View chart
Direct Digital Holdings *w Exp 02/15/202	0.1	$108k		180k	0.60	View chart
Nocturne Acquisition Corp Right 12/26/2025 (MBTCR)	0.0	$78k		500k	0.16	View chart
Nexgel *w Exp 12/01/202 (NXGLW)	0.0	$77k		225k	0.34	View chart
Cingulate *w Exp 12/10/202 (CINGW)	0.0	$45k		270k	0.17	View chart
Onfolio Holdings *w Exp 01/02/202 (ONFOW)	0.0	$27k		200k	0.13	View chart
Pepperlime Health Acqustn *w Exp 10/01/202	0.0	$26k		368k	0.07	View chart
Jeffs Brands *w Exp 08/26/202 (JFBRW)	0.0	$21k		481k	0.04	View chart
Nls Pharmaceutics *w Exp 02/02/202 (NLSPW)	0.0	$21k		200k	0.11	View chart
Prosomnus *w Exp 04/20/202 (OSAAW)	0.0	$11k		150k	0.07	View chart
Bitcoin Depot *w Exp 06/30/202 (BTMWW)	0.0	$9.5k	NEW	50k	0.19	View chart
Cea Industries *w Exp 02/11/202 (CEADW)	0.0	$9.2k		250k	0.04	View chart
Harbor Custom Development In *w Exp 10/07/202 (HCDZQ)	0.0	$6.4k		650k	0.01	View chart
Tg Venture Acquisition Corp *w Exp 08/15/202	0.0	$6.4k		200k	0.03	View chart
Harbor Custom Development In *w Exp 05/09/202 (HCDWQ)	0.0	$4.5k		600k	0.01	View chart
Conduit Pharmaceuticals *w Exp 09/22/202 (CDTTW)	0.0	$4.5k	NEW	100k	0.04	View chart
Chavant Capital Acquisitn *w Exp 99/99/999	0.0	$4.4k		150k	0.03	View chart
Coliseum Acquisition Corp *w Exp 08/22/202 (MITAW)	0.0	$3.6k		28k	0.13	View chart
Surrozen *w Exp 08/01/203 (SRZNW)	0.0	$3.4k		82k	0.04	View chart
Digital Health Acquisition C *w Exp 11/02/202 (DHACW)	0.0	$3.3k		150k	0.02	View chart
Western Acqstn Ventures Corp *w Exp 09/01/202 (WAVSW)	0.0	$3.2k		100k	0.03	View chart
Nexalin Technology *w Exp 09/15/202 (NXLIW)	0.0	$2.6k		105k	0.03	View chart
Selina Hospitality *w Exp 10/27/202 (SLNAW)	0.0	$1.4k		101k	0.01	View chart
Opy Acquisition Corp I *w Exp 09/22/202	0.0	$1.4k		50k	0.03	View chart
Tc Biopharm Holdings *w Exp 02/08/202 (TCBPW)	0.0	$393.400700		19k	0.02	View chart
Bruush Oral Care *w Exp 08/03/202 (BRSHW)	0.0	$341.825100	-96%	14k	0.02	View chart
Relativity Acquisition Corp *w Exp 12/15/202 (RACYW)	0.0	$0		100k	0.00	View chart

Past Filings by Altium Capital Management

SEC 13F filings are viewable for Altium Capital Management going back to 2020

Altium Capital Management 2023 Q3 filed Nov. 14, 2023
Altium Capital Management 2023 Q2 filed Aug. 14, 2023
Altium Capital Management 2023 Q1 filed May 15, 2023
Altium Capital Management 2022 Q4 filed Feb. 14, 2023
Altium Capital Management 2022 Q3 filed Nov. 14, 2022
Altium Capital Management 2022 Q2 filed Aug. 15, 2022
Altium Capital Management 2022 Q1 filed May 16, 2022
Altium Capital Management 2021 Q4 filed Feb. 14, 2022
Altium Capital Management 2021 Q3 restated filed Nov. 17, 2021
Altium Capital Management 2021 Q3 filed Nov. 15, 2021
Altium Capital Management 2021 Q2 filed Aug. 13, 2021
Altium Capital Management 2021 Q1 filed May 6, 2021
Altium Capital Management 2020 Q4 restated filed May 5, 2021
Altium Capital Management 2020 Q4 filed Feb. 16, 2021

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z